A Targeted Enzyme Approach to Sensitization of Tyrosine Kinase Inhibitor-Resistant Breast Cancer Cells

Experimental Cell Research - United States
doi 10.1016/j.yexcr.2012.06.001
Full Text
Abstract

Available in full text

Categories
Cell Biology
Date
Authors
Publisher

Elsevier BV

Related search

X-Linked Inhibitor of Apoptosis Protein Inhibits Apoptosis in Inflammatory Breast Cancer Cells With Acquired Resistance to an ErbB1/2 Tyrosine Kinase Inhibitor

Molecular Cancer Therapeutics
Cancer ResearchOncology
2010English

Evaluation of a Tyrosine Kinase Peptide Microarray for Tyrosine Kinase Inhibitor Therapy Selection in Cancer

Experimental & Molecular Medicine
2016English

E7080, a Multi-Targeted Tyrosine Kinase Inhibitor Suppresses Tumor Cell Migration and Invasion

BMC Cancer
Cancer ResearchOncologyGenetics
2011English

Receptor Tyrosine Kinase Expression Predicts Response to Sunitinib in Breast Cancer

Annals of Surgical Oncology
OncologySurgery
2015English

Forskolin Increases the Effect of Everolimus on Aromatase Inhibitor-Resistant Breast Cancer Cells

Oncotarget
Oncology
2018English

A Novel Isoform of the B Cell Tyrosine Kinase BTK Protects Breast Cancer Cells From Apoptosis

Genes Chromosomes and Cancer
Cancer ResearchGenetics
2013English

Tyrosine Kinase Signalling in Breast Cancer: ErbB Family Receptor Tyrosine Kinases

Breast Cancer Research
Cancer ResearchOncology
2000English

A Chimeric SERM-Histone Deacetylase Inhibitor Approach to Breast Cancer Therapy

ChemMedChem
Organic ChemistryMolecular MedicinePharmacologyBiochemistryToxicologyDrug DiscoveryPharmaceutics
2013English

Profiles of miRNAs Matched to Biology in Aromatase Inhibitor Resistant Breast Cancer

Oncotarget
Oncology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy